Rationale and Design of the Oral HEMe Iron Polypeptide Against Treatment With Oral Controlled Release Iron Tablets Trial for the Correction of Anaemia in Peritoneal Dialysis Patients (HEMATOCRIT Trial)
BMC Nephrology - United Kingdom
doi 10.1186/1471-2369-10-20
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 28, 2009
Authors
Publisher
Springer Science and Business Media LLC